The present study demonstrates that ovine placental lactogen (oPL) (ovine chorionic somatotrophin) may have an important role in the mammogenesis and/or lactogenesis of the ewe. Its effects were compared with that already described for ovine growth hormone (oGH).In the first experiment, 40 nulliparous ewes were induced to lactate by means of a 7 day (days 1-7) oestro-progestative treatment (E 2 +P 4 ). The ewes from Group 1 (n=12) received no further treatment, while those of the other groups received either recombinant oGH (roGH, 28 µg/kg, i.m., twice daily, Group 2, n=12) or recombinant oPL (roPL, 79 µg/kg, i.m., twice daily, Group 3, n=12) from day 11 to 20. All ewes received 25 mg hydrocortisone acetate (HC) twice daily on days 18-20. Control Group 00 (n=2) received no steroid treatment at all, and the control Group 0 (n=2) received only the E 2 +P 4 treatment. Thirteen ewes (three from each experimental group and the two of each control group) were slaughtered at the end of hormone treatments (day 21) before any milking stimulus. The 27 remaining ewes from Groups 1-3 were machine-milked and milk yields recorded daily from day 21 to 76. The E 2 +P 4 treatment enhanced the plasma levels of oPRL, oGH and IGF-I between days 1 and 7 by 1·5, 2·3 and 2·6 times respectively (P=0·002); roGH treatment induced a highly significant enhancement of IGF-I plasma levels from day 11 to 20, whereas a similar effect appeared for roPL-treated ewes only from day 17 to 20 (P<0·01). Eight weeks after the last exogenous hormone injections, milk yields of both roGHand roPL-treated groups progressively rose to twice that of unsupplemented groups (P<0·001). The mammary DNA content on day 21 was higher for animals which received either oGH or oPL but, due to individual variations in so few samples (n=3), this difference was not significant. No -casein was measured in mammary tissue from control ewes, whereas steroid-treated ewes (E 2 +P 4 +HC) had higher casein concentrations regardless of subsequent hormonal treatment on days 11-20 (P<0·001). -Casein concentrations in mammary parenchyma of roGH-treated ewes did not differ from that of ewes which received only E 2 +P 4 +HC; roPL supplementation clearly enhanced expression of -casein (P<0·001).IGF-I stimulation by either roGH or roPL was more precisely examined during a second experiment, in which two twice-daily i.m. doses (58 or 116 µg/kg) of either roGH or roPL were administered to four groups of six ewes that were E 2 +P 4 treated as those of Experiment 1. A control group (n=6) received no exogenous hormone from day 11 to 13. On day 13, hourly blood samples were taken from all ewes over 11 h. Both doses of roGH significantly stimulated IGF-I in a dose-dependent manner. The 58 µg/kg dose of roPL did not significantly stimulate IGF-I, but although being somewhat less efficient than the 58 µg/kg dose of roGH, the 116 µg/kg dose of roPL significantly stimulated IGF-I secretion (P<0·001).These results suggest that mammogenesis and/or lactogenesis in the ewe is in part controlled...